TD Cowen Reiterates Buy on Abbott Laboratories, Maintains $115 Price Target

Benzinga · 2d ago
TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintains $115 price target.